AVBP Operating Cash Flow (Statement)
Arrivent Biopharma Inc · Operating Cash Flow (Statement)
AVBP Operating Cash Flow (Statement)
Latest reported-$147.93Mperiod ending
AVBP TTM Cash from Operations (-$51.30M → -$147.93M)
TTM operating cash flow (statement)
High-resolution chart · PNG
AVBP operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -147,929,000 | |
| -134,472,000 | |
| -160,588,000 | |
| -146,082,000 | |
| -126,629,000 | |
| -119,592,000 | |
| -70,212,000 | |
| -68,973,000 | |
| -68,070,000 | |
| -57,589,000 | |
| -55,842,000 | |
| -56,816,000 | |
| -51,300,000 |